Related Experiment Video
Updated: May 18, 2026
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Deciphering the molecular nature of ovarian cancer biomarker CA125
Florian Weiland1, Karina Martin1, Martin K Oehler2
1Adelaide Proteomics Centre, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5005, Australia.
Abstract:
The ovarian cancer biomarker CA125 has been extensively investigated over the last 30 years. The knowledge about the exact molecular nature of this protein, however, remains fragmented. This review provides an overview of the structural research regarding CA125, and presents an orthogonal verification method to confirm the identity of this molecule. The need for independent identification of CA125 is exemplified by several reports where mutually exclusive data concerning the existence of isoforms and the glycan moieties is presented. Mass spectrometry can overcome the pitfalls of a single detection/identification method such as antibody probing. Independent verification of CA125 identity in characterization studies will help establish a refined model of its molecular structure that will promote the development of new approaches for diagnosis, prognosis and therapy of ovarian cancer.
Insights
The ovarian cancer biomarker CA125
Area of Science:
- Biochemistry
- Oncology
- Proteomics
Background:
- CA125 is a key biomarker for ovarian cancer, but its molecular structure remains poorly understood.
- Existing research on CA125 isoforms and glycans presents conflicting data.
- Accurate characterization is crucial for improving ovarian cancer diagnostics and therapeutics.
Purpose of the Study:
- To review structural research on the ovarian cancer biomarker CA125.
- To present mass spectrometry as an orthogonal verification method for CA125 identity.
- To highlight the need for independent identification to refine CA125's molecular model.
Main Methods:
- Review of existing structural studies on CA125.
- Discussion of mass spectrometry as an independent verification technique.
- Analysis of conflicting data regarding CA125 isoforms and glycan structures.
Main Results:
- Fragmented knowledge persists regarding CA125's exact molecular nature.
- Mass spectrometry offers a robust method to overcome limitations of antibody-based detection.
- Conflicting reports necessitate independent verification of CA125 identity.
Conclusions:
- Independent verification of CA125 identity is essential for accurate molecular characterization.
- Refined understanding of CA125 structure will advance ovarian cancer diagnosis, prognosis, and therapy.
- Mass spectrometry is a key tool for establishing a definitive CA125 molecular model.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010